BioCentury
ARTICLE | Politics & Policy

China releases final results of centralized procurement bids

December 7, 2018 10:43 PM UTC

China's Joint Procurement Office released the final results of its centralized procurement pilot program Friday, in which winning bidders agreed to price cuts up to about 90% for 25 generics.

State-owned Shanghai Securities News reported Thursday significantly discounted prices in the program, including a 90% cut for antiviral entecavir. According to the list released Friday, Sino Biopharmaceutical Ltd. (HKSE:1177) won the tender for entecavir (see "Chinese Biopharma Stocks Plummet After Centralized Tendering Report")...

BCIQ Company Profiles

Sino Biopharmaceutical Ltd.